Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma
about
Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian "Real-World" SAX Study.Axitinib in metastatic renal cell carcinoma: beyond the second-line setting.Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma.Comprehensive analysis and validation of contemporary survival prognosticators in Korean patients with metastatic renal cell carcinoma treated with targeted therapy: prognostic impact of pretreatment neutrophil-to-lymphocyte ratio.Prognostic Significance of Early Tumor Shrinkage Under Second-Line Targeted Therapy for Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Study in Japan.Network meta-analysis of second-line treatment in metastatic renal cell carcinoma: efficacy and safety.Axitinib-induced proteinuria and efficacy in patients with metastatic renal cell carcinoma.Early Tumor Shrinkage Under Treatment with First-line Tyrosine Kinase Inhibitors as a Predictor of Overall Survival in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Multi-Institutional Study in Japan.Long-term Duration of First-Line Axitinib Treatment in Advanced Renal Cell Carcinoma.Evaluation of tumor burden after sequential molecular-targeted therapy in patients with metastatic renal cell carcinoma.Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy.RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial.Predictive Factors for Second-Line Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Analysis.The magnitude of best tumor shrinkage during second-line targeted therapy affects progression-free survival but not overall survival in patients with metastatic renal cell carcinoma.Imaging Response of Antiangiogenic and Immune-Oncology Drugs in Metastatic Renal Cell Carcinoma (mRCC): Current Status and Future ChallengesmiR-9-5p in Nephrectomy Specimens is a Potential Predictor of Primary Resistance to First-Line Treatment with Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell Carcinoma
P2860
Q37290050-F41EF546-9876-4E5D-83A9-F0BBC9A3DC88Q38657787-891130D7-4959-4662-89BB-C84C733C5F1BQ38799848-BB5EECF0-24D1-4227-9D56-5A7989344B63Q39945553-62EA9A23-FC48-4C65-9188-5DFCB71C72CAQ40754987-74D1CD45-8A80-4862-BE8B-2D1EAC64ED6CQ47813600-585F2302-1717-4857-9A2D-E460373CA36FQ47933295-F29D2EB1-F7C0-485C-9874-9FFC1C9028E2Q48014067-CA4F6F5C-EBF9-4E7A-ADB8-007DD751DE11Q50762112-8844BCA2-6A6F-459E-8474-E40691555416Q50984279-CFCC4FE2-F31A-4CF3-B14B-0686C5F8D47FQ51557110-108A0FC4-4FD5-4E5A-BE85-EDD27CF8DA18Q53197402-863E85DF-6D94-4260-9C34-4C96C6F8FDE9Q53634559-B41D4C43-2FA4-443D-808A-9BBF11FEFB0AQ55026900-BB3C5919-3EEF-4BE2-AE15-CDB9405C1C1AQ58585071-75E67911-7107-4896-B91F-463E9397A3E0Q58753441-515CC0CB-2A6B-4E7C-9DC1-1A8213F7721C
P2860
Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Depth of remission is a progno ...... etastatic renal cell carcinoma
@ast
Depth of remission is a progno ...... etastatic renal cell carcinoma
@en
type
label
Depth of remission is a progno ...... etastatic renal cell carcinoma
@ast
Depth of remission is a progno ...... etastatic renal cell carcinoma
@en
prefLabel
Depth of remission is a progno ...... etastatic renal cell carcinoma
@ast
Depth of remission is a progno ...... etastatic renal cell carcinoma
@en
P2093
P2860
P1433
P1476
Depth of remission is a progno ...... etastatic renal cell carcinoma
@en
P2093
Daniel Kalanovic
Julia J Perkins
Katherine M Krajewski
Rana R McKay
Toni K Choueiri
Viktor Grünwald
P2860
P304
P356
10.1016/J.EURURO.2014.12.036
P407
P50
P577
2015-01-07T00:00:00Z